Adrian Gill

Adrian Gill has an extensive background in medicinal chemistry and drug discovery. With experience in various leadership roles at companies like REVOLUTION Medicines, AstraZeneca, Astex Therapeutics, and Roche, Adrian has played key roles in advancing drug development programs. Adrian holds a DPhil in Synthetic Organic Chemistry from the University of Sussex. Currently serving as Executive Vice President and Head of Early Discovery at REVOLUTION Medicines, Adrian previously held leadership positions such as Senior Director External Innovation at AstraZeneca and Team Leader at Roche. Adrian's expertise in medicinal chemistry, analytics, computational chemistry, and structural biology has contributed to the success of multiple drug projects throughout their career.